Treatment of “poor risk” acute nonlymphocytic leukemia with continuously infused low‐dose cytosine arabinoside

E. P. Balaban, J. V. Cox, N. R. Schneider, C. A. Harth, B. B. Haley, R. Sheehan, E. P. Frenkel

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of “poor risk” acute nonlymphocytic leukemia with continuously infused low‐dose cytosine arabinoside'. Together they form a unique fingerprint.

Medicine & Life Sciences